TERMINATED

Sugammadex vs Neostigmine Reversal in Pediatric Appendectomy

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study is designed as a randomized controlled trial with patients assigned to neuromuscular reversal with either sugammadex or neostigmine/glycopyrrolate reversal. The study will not be blinded to the anesthesiologist to allow for appropriate decision-making on timing and dosage of reversal. This is a single-center study.

Official Title

Effectiveness of Sugammadex Versus Neostigmine on Neuromuscular Reversal in Pediatric Patients Undergoing Laparoscopic Appendectomy for Acute Appendicitis: A Randomized Controlled Trial

Quick Facts

Study Start:2023-07-19
Study Completion:2024-08-05
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:TERMINATED

Study ID

NCT05256901

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:2 Years to 17 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * Patients 2-17 years of age
  2. * Diagnosis of acute appendicitis
  3. * Patient undergoing laparoscopic appendectomy at Children's Healthcare of Atlanta- Egleston.
  4. * Parent or Legal Authorized Representative willing to participate, able to understand and sign an informed consent
  1. * Patient with an allergy to Sugammadex or Neostigmine
  2. * History of renal dysfunction
  3. * Parent or legal guardian unwilling or unable or unable to understand the informed consent

Contacts and Locations

Principal Investigator

Laura Gilbertson, MD
PRINCIPAL_INVESTIGATOR
Emory University

Study Locations (Sites)

Children's Healthcare of Atlanta
Atlanta, Georgia, 30329
United States

Collaborators and Investigators

Sponsor: Emory University

  • Laura Gilbertson, MD, PRINCIPAL_INVESTIGATOR, Emory University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-07-19
Study Completion Date2024-08-05

Study Record Updates

Study Start Date2023-07-19
Study Completion Date2024-08-05

Terms related to this study

Keywords Provided by Researchers

  • laparoscopic

Additional Relevant MeSH Terms

  • Appendicitis
  • Surgery